Amarantus Bioscience Holdings Inc (AMBS): AMBS has licensed a Phase 2 drug candida...

Amarantus Bioscience Holdings Inc (AMBS)

Reply Private New

Replies (1) Next 10 Prev Next

Send PM Follow Ignore

Followers	13
Posts	697
Boards Moderated	0
Alias Born	01/12/2013

Skeetz99

Re: None

Tuesday, 10/22/2013 9:13:59 AM

Tuesday, October 22, 2013 9:13:59 AM

AMBS has licensed a Phase 2 drug candidate for L-Dopa-Induced Dyskinesia Parkinson’s Disease from an undisclosed third party (that news was announced several months ago). More importantly, I am a shareholder of AVNR (this AM; they announced trial news for their respective Phase 2 drug for Levodopa Induced Dyskinesia related to Parkinsons). See link below!

http://finance.yahoo.com/news/avanir-pharmaceuticals-announces-enrollment-first-123000825.html

In the process of elimination; we can rule Avanir out as being the mystery company (since AMBS was not mentioned or has not issued news this AM).

Item 8.01 Other Events.

On May 22, 2013, the Company entered into a letter of intent to in-license a Phase 2 drug candidate in L-Dopa-Induced Dyskinesia Parkinson’s Disease from an undisclosed third party. Once licensed the Company intends to initiate a Phase 2b clinical trial within 12 months.